|Mr. Matthew N. Hulett||CEO, Pres & Director||498.7k||N/A||1971|
|Mr. Bruce S. Rosenbloom||CFO & Treasurer||487.96k||N/A||1969|
|Mr. Mark Moseley||Chief Technology & Information Officer||N/A||N/A||N/A|
|Mr. Daniel Job Pingree||Chief Marketing Officer||N/A||N/A||N/A|
|Ms. Jacqueline Smith||VP of People||N/A||N/A||N/A|
|Wendy Zalai||Corp. Controller & Corp. Sec.||N/A||N/A||N/A|
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
PetMed Express, Inc.’s ISS governance QualityScore as of 1 June 2022 is 1. The pillar scores are Audit: 6; Board: 2; Shareholder rights: 1; Compensation: 3.